Home/Speakers/Eleni Gagari

Eleni Gagari

Precancer and cancer of the oral mucosa: diagnosis, management and prevention of a complex oral disease

  • She obtained her DDS from National and Kapodistrian University School of Dentistry and her DMD from Tufts University School of Dental Medicine (faculty development program). She is licensed to practice denitstry in both United States and Greece.
  • She completed a certificate in oral and maxillofacial pathology/Doctor of Medical Sciences program at Harvard School of Dental Medicine.
  • She is a Diplomate of the American Board of Oral and Maxillofacial Pathology and a Fellow of the American Academy of Oral and Maxillofacial Pathology.
  • While in the US she pursued an academic holding the positions of instructor, assistant professor and associate professor at Harvard School of Dental Medicine, NYUCD and TUSDM respectively.
  • In 2008, she moved to Greece where she took over one of the world’s largest oral mucosal disease clinical services in the Department of Dermatology in NKUA School of Medicine.
  • She is a sought-after lecturer and is considered a highly skilled educator and mentor in her chosen field.

Nationality: Greece

Scientific areas: Oral medicine

9 of november, from 09h00 until 13h00

Auditorium B

Conference summary

Oral premalignant and malignant lesions are life-threatening conditions. The ability of the dental care provider to accurately and correctly identify them is critical in determining disease outcome and patient prognosis.

This presentation will endeavor to outline the spectrum of oral carcinogenesis so that the clinician will be able to recognize the hallmarks of it and manage the patient accordingly. Specifically:

Part I: Precancerous Lesions of the Oral Mucosa

This presentation will focus on:

  • What premalignant lesions look like in the oral cavity (color, texture, location, age/sex prevalence) and the differential diagnosis involved.
  • When to make the decision to biopsy these lesions.
  • How to interpret the biopsy results.
  • How to manage the patient.
  • What are the implications for dental care of a patient with oral premalignancy.

Part II: Oral Cancer of the Oral Mucosa

This presentation will focus on:

  • Clinical appearance, differential diagnosis and epidemiology of oral cancer.
  • How to biopsy an oral lesion suspected of being oral cancer.
  • Oral cancer types of treatment and their implications on oral health.
  • Managing the oral health of a patient with incurable oral cancer (terminal disease).